165 related articles for article (PubMed ID: 24209894)
21. Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney.
Lin HH; Liu YL; Liu JH; Chou CY; Yang YF; Kuo HL; Huang CC
Artif Organs; 2008 Jun; 32(6):468-72. PubMed ID: 18422797
[TBL] [Abstract][Full Text] [Related]
22. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
23. [Does uremic pruritus in hemodialyzed patients disappear only with replacement therapy?].
Jakić M
Lijec Vjesn; 1999; 121(4-5):118-22. PubMed ID: 10437354
[TBL] [Abstract][Full Text] [Related]
24. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
25. Hemodialysis-related pruritus and associated cutaneous manifestations.
Dyachenko P; Shustak A; Rozenman D
Int J Dermatol; 2006 Jun; 45(6):664-7. PubMed ID: 16796623
[TBL] [Abstract][Full Text] [Related]
26. Curative effect of neutral macroporous resin hemoperfusion on treating hemodialysis patients with refractory uremic pruritus.
Li WH; Yin YM; Chen H; Wang XD; Yun H; Li H; Luo J; Wang JW
Medicine (Baltimore); 2017 Mar; 96(12):e6160. PubMed ID: 28328802
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics of pruritus in hemodialysis patients].
Mesić E; Tabaković M; Habul V; Atić M; Lekić S; Resić H; Halilbasić A; Trnacević S; Halilbasić A
Acta Med Croatica; 2004; 58(5):377-80. PubMed ID: 15756803
[TBL] [Abstract][Full Text] [Related]
28. Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients.
Wang XH; Zhang X; Mu CJ; He Y; Peng QP; Yang GS; Li MM; Liu D; Li J; Ding GH
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):508-513. PubMed ID: 26223918
[TBL] [Abstract][Full Text] [Related]
29. Pruritus in hemodialysis patients.
Akhyani M; Ganji MR; Samadi N; Khamesan B; Daneshpazhooh M
BMC Dermatol; 2005 Jun; 5():7. PubMed ID: 15975150
[TBL] [Abstract][Full Text] [Related]
30. Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Cooper K; Quarles D; Kubo Y; Tomlin H; Goodman W
Nephron Clin Pract; 2012; 121(3-4):c124-30. PubMed ID: 23208191
[TBL] [Abstract][Full Text] [Related]
31. Gabapentin and uremic pruritus in hemodialysis patients.
Razeghi E; Eskandari D; Ganji MR; Meysamie AP; Togha M; Khashayar P
Ren Fail; 2009; 31(2):85-90. PubMed ID: 19212903
[TBL] [Abstract][Full Text] [Related]
32. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.
Narita I; Alchi B; Omori K; Sato F; Ajiro J; Saga D; Kondo D; Skatsume M; Maruyama S; Kazama JJ; Akazawa K; Gejyo F
Kidney Int; 2006 May; 69(9):1626-32. PubMed ID: 16672924
[TBL] [Abstract][Full Text] [Related]
33. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications.
Fallahzadeh MK; Roozbeh J; Geramizadeh B; Namazi MR
Nephrol Dial Transplant; 2011 Oct; 26(10):3338-44. PubMed ID: 21372257
[TBL] [Abstract][Full Text] [Related]
36. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
[TBL] [Abstract][Full Text] [Related]
37. Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
Wu-Wong JR; Nakane M; Chen YW
Life Sci; 2013 Feb; 92(2):161-6. PubMed ID: 23261531
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients.
Rossi GM; Corradini M; Blanco V; Mattei S; Fiaccadori E; Vaglio A; Manenti L
Intern Emerg Med; 2019 Nov; 14(8):1341-1346. PubMed ID: 31494816
[No Abstract] [Full Text] [Related]
39. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
40. Itchy skin--a clinical problem for haemodialysis patients.
Wikström B
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v3-7. PubMed ID: 17586843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
